Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 2
1970 1
1971 2
1972 1
1973 1
1975 1
1977 2
1978 1
1979 5
1980 1
1981 2
1982 2
1984 1
1985 2
1987 3
1988 1
1991 1
1992 2
1993 4
1994 3
1996 4
1998 1
1999 1
2000 2
2008 1
2009 1
2010 1
2011 1
2012 1
2013 1
2014 3
2015 2
2016 2
2017 10
2018 7
2019 7
2020 7
2021 9
2022 8
2023 10
2024 14
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

123 results

Results by year

Filters applied: . Clear all
Page 1
Nutritional Status and Oral Frailty: A Community Based Study.
Nomura Y, Ishii Y, Suzuki S, Morita K, Suzuki A, Suzuki S, Tanabe J, Ishiwata Y, Yamakawa K, Chiba Y, Ishikawa M, Sogabe K, Kakuta E, Okada A, Otsuka R, Hanada N. Nomura Y, et al. Among authors: sogabe k. Nutrients. 2020 Sep 21;12(9):2886. doi: 10.3390/nu12092886. Nutrients. 2020. PMID: 32967313 Free PMC article.
DAPagliflozin for the attenuation of albuminuria in Patients with hEaRt failure and type 2 diabetes (DAPPER study): a multicentre, randomised, open-label, parallel-group, standard treatment-controlled trial.
Yoshihara F, Imazu M, Sakuma I, Hiroi Y, Hara H, Okazaki O, Ishiguro C, Izumi C, Noguchi T, Shiraiwa T, Nishioka N, Fujii K, Iwakura K, Tomonaga O, Kobayashi K, Takihata M, Yumoto K, Takase H, Himi T, Shimizu I, Murakami T, Wagatsuma K, Sato K, Hiramatsu T, Akabame S, Hata S, Asakura M, Kawabata T, Omae K, Ito S, Kitakaze M; DAPPER Investigators. Yoshihara F, et al. EClinicalMedicine. 2023 Nov 27;66:102334. doi: 10.1016/j.eclinm.2023.102334. eCollection 2023 Dec. EClinicalMedicine. 2023. PMID: 38192595 Free PMC article.
Structure and Validity of Questionnaire for Oral Frail Screening.
Nomura Y, Ishii Y, Chiba Y, Suzuki S, Suzuki A, Suzuki S, Morita K, Tanabe J, Yamakawa K, Ishiwata Y, Ishikawa M, Sogabe K, Kakuta E, Okada A, Otsuka R, Hanada N. Nomura Y, et al. Among authors: sogabe k. Healthcare (Basel). 2021 Jan 5;9(1):45. doi: 10.3390/healthcare9010045. Healthcare (Basel). 2021. PMID: 33466528 Free PMC article.
Acute accumulation of PIM2 and NRF2 and recovery of β5 subunit activity mitigate multiple myeloma cell susceptibility to proteasome inhibitors.
Sogabe K, Nakamura S, Higa Y, Miki H, Oda A, Maruhashi T, Sumitani R, Oura M, Takahashi M, Nakamura M, Maeda Y, Hara T, Yamagami H, Fujii S, Kagawa K, Ozaki S, Kurahashi K, Endo I, Aihara KI, Nakaue E, Hiasa M, Teramachi J, Harada T, Abe M. Sogabe K, et al. Int J Hematol. 2024 Mar;119(3):303-315. doi: 10.1007/s12185-023-03705-9. Epub 2024 Jan 21. Int J Hematol. 2024. PMID: 38245883
Mechanical unloading aggravates bone destruction and tumor expansion in myeloma.
Tanimoto K, Hiasa M, Tenshin H, Teramachi J, Oda A, Harada T, Higa Y, Sogabe K, Oura M, Sumitani R, Hara T, Endo I, Matsumoto T, Tanaka E, Abe M. Tanimoto K, et al. Among authors: sogabe k. Haematologica. 2022 Mar 1;107(3):744-749. doi: 10.3324/haematol.2021.278295. Haematologica. 2022. PMID: 34788982 Free PMC article. No abstract available.
Novel antimyeloma therapeutic option with inhibition of the HDAC1-IRF4 axis and PIM kinase.
Harada T, Ohguchi H, Oda A, Nakao M, Teramachi J, Hiasa M, Sumitani R, Oura M, Sogabe K, Maruhashi T, Takahashi M, Fujii S, Nakamura S, Miki H, Kagawa K, Ozaki S, Sano S, Hideshima T, Abe M. Harada T, et al. Among authors: sogabe k. Blood Adv. 2023 Mar 28;7(6):1019-1032. doi: 10.1182/bloodadvances.2022007155. Blood Adv. 2023. PMID: 36129197 Free PMC article.
The Xanthine Oxidase Inhibitor Febuxostat Suppresses Adipogenesis and Activates Nrf2.
Higa Y, Hiasa M, Tenshin H, Nakaue E, Tanaka M, Kim S, Nakagawa M, Shimizu S, Tanimoto K, Teramachi J, Harada T, Oda A, Oura M, Sogabe K, Hara T, Sumitani R, Maruhashi T, Yamagami H, Endo I, Matsumoto T, Tanaka E, Abe M. Higa Y, et al. Among authors: sogabe k. Antioxidants (Basel). 2023 Jan 5;12(1):133. doi: 10.3390/antiox12010133. Antioxidants (Basel). 2023. PMID: 36670994 Free PMC article.
123 results